Kemps-Polanco Reshema bought CRL
February 1, 2024 · Form 4 insider transaction
Kemps-Polanco Reshema bought 399 shares of Charles River Laboratories International, Inc. at $219.54 per share, a transaction worth $87.6K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
399
Price
$219.54
Total value
$87.6K
InsiderKemps-Polanco Reshema
Role—
SecurityStock Options (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 1, 2024
Filing dateFebruary 5, 2024
Shares owned after399
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock options become exercisable 5/7/2024.